In vivo assessment of pigmented skin lesions by Raman spectroscopy

• Conditions: Melanoma; mole.; skin cancer of pigment-containing cells. Nevus; 10040900

• Registration Number: NL-OMON43252
• Lead Sponsor: eids Universitair Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

Adult, mentally competent persons with pigmented skin lesions

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study:
- the lesion(s) are on body locations inaccessible to the Raman measurement
- patient is physically capable of undergoing the Raman measurement (which requires the patient to not move during the measurement)
- patient is mentally not capable of participation, e.g. because of anxiety

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Clinical and when available the pathological diagnosis of the pigmented skin<br /><br>lesion (melanoma or benign skin lesion) will be correlated with the measured<br /><br>Raman spectra of the lesions. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Age of the patient, location and aspect of the lesion, clinical differential<br /><br>diagnosis. </p><br>